Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 May 2023 for Relmada Therapeutics, INC., €30k.
Filing timeline
BuySaleCedric O'Gorman
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +7.4%Entry US$2.84 · Close at T+365 US$3.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cedric O'Gorman: trading record in brief
Only one filing by Cedric O'Gorman is known so far (24 May 2023): an open-market purchase, €30k, in Relmada Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cedric O'Gorman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 10,000 shares@ US$3.18100.0% of flowCommon StockSEC:0001213900-23-042554:0Canonical exit: 21 Aug 2023 (T+90)
1 of 1 declaration